HDAC9 and acute kidney injury: Outside of HDAC biology, these findings hold clinical significance for their potential to facilitate new therapies for AKI, an exceedingly common and expensive medical problem that affects more than one million Americans per year, with costs in the billions of dollars annually1–6.